British pharma contender GlaxoSmithKline ($GSK) is striving to regain relevance in a field long overshadowed by its rivals ...

The company says it will invest $6.5 billion in a manufacturing facility at the Generation Park complex in Houston. Lilly ...

The FDA reapproved a GSK drug that stopped being sold more than 25 years ago, as part of a push to identify potential ...

GSK’s mega investment includes a new 1.2-billion-dollar investment in advanced manufacturing facilities and AI and advanced ...

Leucovorin, also known as folinic acid, is a form of folate, an essential B vitamin, or B9. Leucovorin has been approved by ...

The GlaxoSmithKline drug, which can be taken orally or intravenously, is made by more than half a dozen companies.

(Reuters) -On Monday, the U.S. Food and Drug Administration published a notice to the Federal Register ahead of a speech by ...

Get the latest stock market updates and key healthcare news, including top performers, FDA actions, and major investments.

MINNEAPOLIS--(BUSINESS WIRE)--Niron Magnetics, the world’s only producer of powerful rare-earth-free permanent magnets, today announced the grand opening of its commercial pilot plant in Minneapolis.

British pharmaceutical firm GSK has pledged to invest $30 billion (£22 billion) in research and manufacturing in the United ...

This episode of Pharma Pulse covers GSK’s $30 billion plan to expand US biopharma production, new evidence that weekly GLP-1 therapies significantly reduce cardiovascular risks, and Roche’s ...